Improving pragmatic clinical trial design using real-world data

Clinical Trials

Volumn 16, Issue 3, 2019, Pages 273-282

  Shortreed, Susan M ^a,b   Rutter, Carolyn M ^c   Cook, Andrea J ^a,b   Simon, Gregory E ^a  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c RAND CORPORATION   (United States)

Author keywords

Electronic medical records; mental health; power calculations; pragmatic clinical trials; randomized trial design; sample size calculations; study design; suicide prevention

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ELECTRONIC HEALTH RECORD; EVALUATION STUDY; FEMALE; HEALTH CARE; HEALTH IMPACT ASSESSMENT; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MOTIVATION; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT HEALTH QUESTIONNAIRE; PRAGMATIC TRIAL; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; STUDY DESIGN; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT; COMPUTER SIMULATION; MENTAL HEALTH; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); UNITED STATES;

COMPUTER SIMULATION; ELECTRONIC HEALTH RECORDS; HUMANS; MENTAL HEALTH; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SAMPLE SIZE; SUICIDE; UNITED STATES;

EID: 85062986980     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774519833679     Document Type: Article

References (28)

1. Thorpe KE, Zwarenstein M, Oxman AD, et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol 2009; 62: 464–475.
2. Van Staa TP, Goldacre B, Gulliford M, et al. Pragmatic randomised trials using routine electronic health records: putting them to the test. BMJ 2012; 344: e55.
3. Chalkidou K, Tunis S, Whicher D, et al. The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research. Clin Trials 2012; 9(4): 436–446.
4. Califf RM., Pragmatic clinical trials: emerging challenges and new roles for statisticians. Clin Trials 2016; 13(5): 471–477.
5. Behrman RE, Benner JS, Brown JS, et al. Developing the sentinel system–a national resource for evidence development. N Engl J Med 2011; 364(6): 498–499.
6. Platt R, Davis R, Finkelstein J, et al. Multicenter epidemiologic and health services research on therapeutics in the HMO research network center for education and research on therapeutics. Pharmacoepidemiol Drug Saf 2001; 10(5): 373–377.
7. Steiner JF, Paolino AR, Thompson EE, et al. Sustaining research networks: the twenty-year experience of the HMO research network. EGEMS 2014; 2(2): 1067.
8. Vogt TM, Elston-Lafata J, Tolsma D, et al. The role of research in integrated healthcare systems: the HMO research network. Am J Manag Care 2004; 10(9): 643–648.
9. Rossom RC, Simon GE, Beck A, et al. Facilitating action for suicide prevention by learning health care systems. Psychiatr Serv 2016; 67(8): 830–832.
10. Fleurence RL, Curtis LH, Califf RM, et al. Launching PCORnet, a national patient-centered clinical research network. J Am Med Inform Assoc 2014; 21(4): 578–582.
11. NorthWest EHealth. NorthWest EHealth homepage, https://nweh.co.uk/ (2018, accessed 21 December 2018).
12. National Institute for Health Research. National Institute for Health Research homepage, https://www.nihr.ac.uk/ (2018, accessed 21 December 2018).
13. National Institutes of Health. Rethinking clinical trials: NIH Collaboratory Living Textbook, http://rethinkingclinicaltrials.org/ (2018, accessed 21 December 2018).
14. Simon GE, Beck A, Rossom R, et al. Population-based outreach versus care as usual to prevent suicide attempt: study protocol for a randomized controlled trial. Trials 2016; 17(1): 452.
15. Simon GE, Rutter CM, Peterson D, et al. Does response on the PHQ-9 Depression Questionnaire predict subsequent suicide attempt or suicide death? Psychiatr Serv 2013; 64: 1195–1202.
16. Simon GE, Coleman KJ, Rossom RC, et al. Risk of suicide attempt and suicide death following completion of the patient health questionnaire depression module in community practice. J Clin Psychiatry 2016; 77(2): 221–227.
17. Zelen M., A new design for randomized clinical trials. N Engl J Med 1979; 300: 1242–1245.
18. Simon GE, Shortreed SM, Johnson E, et al. Between-visit changes in suicidal ideation and risk of subsequent suicide attempt. Depress Anxiety 2017; 34(9): 794–800.
19. Kaplan EL, Meier P., Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481.
20. NCSS L., PASS 14 power analysis and sample size Software. Kaysville, UT: NCSS, 2015.
21. R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2017.
22. Therneau T. A package for survival analysis in S. Version 2.38, 2015, https://cran.r-project.org/web/packages/survival/index.html
23. Andridge RR, Little RJ., A review of hot deck imputation for survey non-response. Int Stat Rev 2010; 78(1): 40–64.
24. Westreich D, Edwards JK, Lesko CR, et al. Transportability of trial results using inverse odds of sampling weights. Am J Epidemiol 2017; 186: 1010–1014.
25. Stuart EA, Rhodes A., Generalizing treatment effect estimates from sample to population: a case study in the difficulties of finding sufficient data. Eval Rev 2017; 41(4): 357–388.
26. Shortreed SM, VonKorff M, Thielke S, et al. Electronic health records to evaluate and account for non-response bias: a survey of patients using chronic opioid therapy. Obs Stud 2016; 2: 24–38.
27. U.S. Department of Health & Human Services. Guidance regarding methods for de-identification of protected health information in accordance with the health insurance portability and accountability act (HIPAA) privacy rule, https://www.hhs.gov/sites/default/files/ocr/privacy/hipaa/understanding/coveredentities/De-identification/hhs_deid_guidance.pdf (2012, accessed 21 December 2018).
28. Nelson JC, Cook AJ, Yu O, et al. Challenges in the design and analysis of sequentially monitored postmarket safety surveillance evaluations using electronic observational health care data. Pharmacoepidemiol Drug Saf 2012; 21(Suppl. 1): 62–71.